Advertisement
Table 2 Availability and utilization of life saving priority by health workers to treat children under five
| Illness | WHO recommended medicine and dosage form | Dosage form included in EMHSLU (1 = Yes 2 = No) (classification as vital/non-vital for the level) | Availability [N = 32 (%)] | Utilization by health workers (N = 81) % | ||
|---|---|---|---|---|---|---|
| HC II (N = 17) | HC III (N = 10) | HC IV (N = 5) | ||||
| Pneumonia | Amoxicillin Dispersible, scored tablets 250 mg; 500 mg | 2 (non-vital for all HC levels) | 60 (30) | 0 (00) | 02 (40) | 46 (57) |
| Ampicillin Powder for injection 500 mg; 1 g | 1 (non-vital for HC II, vital for HC III & IV) | 00 (00) | 04 (40) | 02 (40) | 20 (24) | |
| Ceftriaxone Powder for injection 500 mg; 1 g | 1 (non-vital for HC II & III, vital for HC IV) | 00 (00) | 00 (0) | 03 (60) | 4 (5) | |
| Gentamycin Injection 40 mg/ml; 20 mg/ml | 1 (non-vital for HC II, vital for HC III & IV) | 04 (20) | 06 (60) | 02 (40) | 30 (37) | |
| Diarrhoea | Oral Rehydration Salt (ORS): Sachets of 200 ml; 500 ml; 1000mls | 1 (vital for all HC levels) | 20(100) | 10 (100) | 03 (60) | 15 (19) |
| Zinc sulphate 20 mg: Dispersible tablet | 1 (vital for all HC levels) | 16 (94) | 10 (100) | 03 (60) | 20 (25) | |
| Malaria | Artemesinin combination therapy (ACT): Dispersible tablets | 2 (non-vital for all HC levels) | 00 (0) | 00 (00) | 00 (00) | 0 (00) |
| Artesunate Injection 50–200 mg | 1 (vital for all HC levels) | 01 (10) | 01 (14.3) | 01 (20) | 0 (00) | |
| Artesunate Rectal 50–200 mg | 1 (vital for all HC levels) | 0 (00) | 0 (00) | 0 (00) | 0 (00) | |
| Neonatal sepsis | Procaine benzyl penicillin; injection 1 g | 1 (non-vital for HC II, vital for HC III & IV) | 14 (82) | 06 (86) | 05 (100) | 70 (86) |
